المؤلفون: Isabelle Monnet, Alain Vergnenègre, Gilles Robinet, Henri Berard, Regine Lamy, Lionel Falchero, Sabine Vieillot, Roland Schott, Charles Ricordel, Stephane Chouabe, Pascal Thomas, Radj Gervais, Anne Madroszyk, Samir Abdiche, Anne Marie Chiappa, Laurent Greillier, Chantal Decroisette, Jean Bernard. Auliac, Christos Chouaïd

المصدر: Therapeutic Advances in Medical Oncology, Vol 13 (2021)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1758-8359

URL الوصول: https://doaj.org/article/a1b5190caa744a0094132ccad24a69d7

المؤلفون: Thibaut Capron, Guillaume Botto, Jean-Jacques Roujon, Jean Miltgen, Henri Berard

المصدر: Respiratory Medicine and Research. :101024

مصطلحات موضوعية: Pulmonary and Respiratory Medicine

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::4186f5bf364717a79b542bced4588e0b
https://doi.org/10.1016/j.resmer.2023.101024

المؤلفون: Nathalie Baize, Christos Chouaid, Lionel Falchero, Patrick Saulnier, Jean-Bernard Auliac, Roland Schott, Groupe Français de Pneumo-Cancérologie – investigators, Laurent Greillier, R. Lamy, Hervé Le Caer, Jacques Letreut, Jacky Crequit, Gwenaelle Le Garff, A. Madroszyk, Radj Gervais, Margaux Geier, Isabelle Monnet, Patrick-Aldo Renault, Alain Vergnenegre, Henri Berard, Eric Dansin, H. Janicot, Hervé Lena

المصدر: The Lancet Oncology. 21:1224-1233

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, medicine.medical_specialty, Adolescent, Drug-Related Side Effects and Adverse Reactions, medicine.medical_treatment, Population, Disease-Free Survival, Carboplatin, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Lung cancer, education, Etoposide, Aged, Chemotherapy, education.field_of_study, business.industry, Combination chemotherapy, Middle Aged, medicine.disease, Small Cell Lung Carcinoma, 030104 developmental biology, Oncology, chemistry, 030220 oncology & carcinogenesis, Female, Topotecan, France, Neoplasm Recurrence, Local, business, Febrile neutropenia, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84b2892288de0f63aa230ce4a3c45fe6
https://doi.org/10.1016/s1470-2045(20)30461-7

المؤلفون: Anne Marie Chiappa, Isabelle Monnet, Radj Gervais, Christos Chouaid, Alain Vergnenegre, S. Vieillot, Jean Bernard Auliac, Roland Schott, Gilles Robinet, Laurent Greillier, Lionel Falchero, Anne Madroszyk, R. Lamy, Pascal Thomas, Charles Ricordel, Samir Abdiche, Stephane Chouabe, Henri Berard, Chantal Decroisette

المساهمون: CHI Créteil, CHU Limoges, Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Hopital d'instruction des armées Sainte-Anne [Toulon] (HIA), Groupe Hospitalier Bretagne Sud (GHBS), Centre Paul Strauss, CRLCC Paul Strauss, CHU Pontchaillou [Rennes], Centre Hospitalier de Charleville-Mezières, Hôpital de GAP, Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU), Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Centre Hospitalier Libourne, CH de Quimper, Hôpital Nord [CHU - APHM]

المصدر: Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology, SAGE Journals, 2021, 13, pp.175883592110069. ⟨10.1177/17588359211006983⟩

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Bevacizumab, medicine.medical_treatment, non-small–cell lung cancer, [SDV.CAN]Life Sciences [q-bio]/Cancer, bevacizumab, Asymptomatic, [SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, law.invention, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, medicine, Lung cancer, pemetrexed, radiotherapy, RC254-282, cerebral metastasis, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Carboplatin, Radiation therapy, 030104 developmental biology, Pemetrexed, chemistry, 030220 oncology & carcinogenesis, medicine.symptom, business, management, medicine.drug, Brain metastasis

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44ff0277eb53f2530508c3b2d27143d2
https://doaj.org/article/a1b5190caa744a0094132ccad24a69d7

المؤلفون: Franck Morin, Judith Raimbourg, Didier Debieuvre, Denis Moro-Sibilot, Elisabeth Quoix, Hugues Morel, Elodie Amour, Olivier Molinier, José Hureaux, Etienne Giroux-Leprieur, Isabelle Rault, Alexis B. Cortot, Benjamin Huret, Josiane Otto, Aldo Renault, L. Moreau, Anne Madroszyk, Sandrine Charpentier, Marc G. Denis, Eric Pichon, Henri Berard, Jacques Cadranel

المساهمون: Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 (CANTHER), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Centre National de la Recherche Scientifique (CNRS), CHU Lille, Intergroupe Francophone de Cancérologie Thoracique [Paris] (IFCT), Intergroupe Francophone de Cancérologie thoracique, Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Biomarqueurs et essais cliniques en Cancérologie et Onco-Hématologie (BECCOH), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Saclay, Hôpital Ambroise Paré [AP-HP], Centre Hospitalier Le Mans (CH Le Mans), CHU Strasbourg, Hopital d'instruction des armées Sainte-Anne [Toulon] (HIA), Centre de Lutte contre le Cancer Antoine Lacassagne [Nice] (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UCA), CHU Amiens-Picardie, Institut d'oncologie/développement Albert Bonniot de Grenoble (INSERM U823), Université Joseph Fourier - Grenoble 1 (UJF)-CHU Grenoble-EFS-Institut National de la Santé et de la Recherche Médicale (INSERM), CRLCC René Gauducheau, Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM), Université Bretagne Loire (UBL), Hôpitaux Civils de Colmar, Centre Hospitalier Régional d'Orléans (CHRO), Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Centre hospitalier universitaire de Nantes (CHU Nantes), CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Bristol-Myers Squibb, BMS, Pfizer, AstraZeneca, Merck, Novartis, Roche, Meso Scale Diagnostics, MSD, Boehringer Ingelheim, Takeda Pharmaceutical Company, TPC, and nonfinancial support from MSD, Takeda, and AbbVie outside the submitted work. E. Pichon reports nonfinancial support from Takeda, personal fees from Roche and AstraZeneca, and nonfinancial support from BMS outside the submitted work. B. Huret reports personal fees from Roche, AstraZeneca, BMS, and Boehringher Ingelheim outside the submitted work. M.G. Denis reports grants and personal fees from AstraZeneca and Takeda, grants from BluePrint Medicines, and personal fees from BMS, Boehringer Ingelheim, Roche Diagnostics, and Amgen outside the submitted work. J. Cadranel reports personal fees from BI, grants and personal fees from AstraZeneca, Pfizer, and Novartis, and personal fees from Roche, MSD, BMS, and Takeda outside the submitted work. No disclosures were reported by the other authors., A.B. Cortot reports grants from Boeringher-Ingelheim during the conduct of the study, as well as personal fees and nonfinancial support from AstraZeneca and Pfizer, grants, personal fees, and nonfinancial support from Roche and Novartis, personal fees and nonfinancial support from MSD, BMS, and Takeda, and grants from Merck, outside the submitted work. A. Madroszyk reports other support from Boehringer and MSD during the conduct of the study, as well as other support from Roche, Pfizer, AstraZeneca, BMS, and Prostrakan outside the submitted work. E. Giroux-Leprieur reports grants, personal fees, and nonfinancial support from AstraZeneca, Bristol Myers Squibb, and Roche, personal fees and nonfinancial support from Boehringer Ingelheim, MSD, and Takeda, and personal fees from Novartis outside the submitted work. O. Molinier reports personal fees from AstraZeneca, MSD, BMS, Amgen, Takeda, and Menarini outside the submitted work. E. Quoix reports grants from Boehringer Ingelheim and Ligue Nationale contre le Cancer during the conduct of the study, as well as personal fees and other from BMS and Chugai, other from Roche and Takeda, and personal fees from Novartis outside the submitted work. H. Bérard reports other from MSD, Roche, and Novartis outside the submitted work. D. Moro-Sibilot reports grants, personal fees, and nonfinancial support from Boehringer Ingelheim, Roche, BMS, Pfizer, AstraZeneca, and Merck, as well as personal fees, Medical writing assistance was provided by Dr Sarah Hopwood (Scinopsis, France), funded by IFCT. We thank the participating patients and their families as well as the study teams involved in the trial, the clinical research assistants, study coordinators, and IFCT operations staff. We thank the staff of the department of Biochemistry, CHU de Nantes. We also thank all the participating investigators: Dr Anne Madroszyk (institut Paoli Calmette, Marseille), Dr Etienne Giroux-Leprieur (hôpital Ambroise Paré, Boulogne), Dr Olivier Molinier (CHG, Le Mans), Pr Elisabeth Quoix (NHC, Strasbourg), Pr Jacques Cadranel (hôpital Tenon, Paris), Dr Henri Bérard (HIA Sainte-Anne, Toulon), Dr Josiane Otto (centre Antoine Lacassagne, Nice), Dr Isabelle Rault (CH, Saint Quentin), Pr Denis Moro-Sibilot (CHU, Grenoble), Pr Alexis B. Cortot (hôpital Calmette, Lille), Dr Judith Raimbourg (Institut de Cancérologie de l’Ouest, Nantes), Dr José Hureaux (CHU Angers), Lionel Moreau (CH Colmar), Dr Didier Debieuvre (GHRMSA, Mulhouse), Dr Hugues Morel (CHR, Orléans), Dr Valérie Gounant (hôpital Bichat, Paris), Dr Ludovic Doucet (hôpital Saint-Louis, Paris), Dr Aldo Renault (CHG, Pau), Dr Eric Pichon (CHU, Tours), Dr Benjamin Huret (hôpital privé, Villeneuve d’Asq), Dr Nadine Dohollou (Polyclinique Bordeaux Nord), Dr Clarisse Audigier-Valette (CHI, Toulon), Dr Chantal Decroisette (CH, Annecy), Dr Mathilde Cabart (Institut Bergonié, Bordeaux), Dr Patrick Merle (CHU, Clermont-Ferrand), Dr Catherine Becht (clinique du Parc, Castelnau le Lez), and Dr Luc Odier (CH, Villefranche sur Saône)., Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre Hospitalier Régional Universitaire de Tours (CHRU TOURS)

المصدر: Clinical Cancer Research
Clinical Cancer Research, American Association for Cancer Research, 2021, 27 (15), pp.4168-4176. ⟨10.1158/1078-0432.CCR-20-4604⟩
Clinical Cancer Research, 2021, 27 (15), pp.4168-4176. ⟨10.1158/1078-0432.CCR-20-4604⟩

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, medicine.drug_class, Afatinib, [SDV.CAN]Life Sciences [q-bio]/Cancer, EGFR Gene Mutation, Tyrosine-kinase inhibitor, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Clinical endpoint, Epidermal growth factor receptor, Adverse effect, Lung cancer, 030304 developmental biology, 0303 health sciences, Cetuximab, biology, business.industry, medicine.disease, 3. Good health, 030220 oncology & carcinogenesis, biology.protein, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76cc6aa17b0f36d03ffa1da497689d14
https://hal.archives-ouvertes.fr/hal-03401841

المؤلفون: Isabelle, Monnet, Alain, Vergnenègre, Gilles, Robinet, Henri, Berard, Regine, Lamy, Lionel, Falchero, Sabine, Vieillot, Roland, Schott, Charles, Ricordel, Stephane, Chouabe, Pascal, Thomas, Radj, Gervais, Anne, Madroszyk, Samir, Abdiche, Anne Marie, Chiappa, Laurent, Greillier, Chantal, Decroisette, Jean Bernard, Auliac, Christos, Chouaïd

المصدر: Therapeutic Advances in Medical Oncology

مصطلحات موضوعية: cerebral metastasis, non-small–cell lung cancer, bevacizumab, pemetrexed, management, radiotherapy, Original Research

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::4cbebf335ad2f21d736f4dd36a0830cb
https://pubmed.ncbi.nlm.nih.gov/33948123

المؤلفون: Nicolas Paleiron, Frédéric Grassin, Christophe Lancelin, Cécile Tromeur, Jacques Margery, Claudia Natale, Francis Couturaud, Christophe Gut-Gobert, Aude Barnier, Elise Noël-Savina, Amélie Bazire, Annabelle Payet, Henri Berard, Michel Andre, Fabien Vaylet, Florent Vinas, Christos Chouaïd, Nicolas Venissac, Christine Donzel-Raynaud, Yvonnick RAUT, Nicolas Salley, Romain Corre, Mallorie Kerjouan, Antoine Cuvelier, Cherifa Gounane, Sonia Blandin, Lionel Falchero, Jacques Le Treut, Olivier Aze, Frédéric Gagnadoux, Wojciech Trzepizur, Alain Vergnenegre, Thomas Egenod, Olivier Tiffet, Eric Parietti

المساهمون: Département de Médecine Interne et Pneumologie [Brest] (DMIP - Brest), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Groupe d'Etude de la Thrombose de Bretagne Occidentale (GETBO), Université de Brest (UBO)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO), Service d'Oncologie Thoracique (BREST - ICH), Service de Cardiologie (HIA BREST - Cardio), HIA - BREST, Laboratoire Transport et Environnement (INRETS/LTE), Institut National de Recherche sur les Transports et leur Sécurité (INRETS), Hôpital d'instruction des Armées Percy, Service de Santé des Armées, Hôpital d'Instruction des Armées Percy, CIC - Biotherapie - CHU Henri Mondor, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Infection bactérienne, inflammation, et carcinogenèse digestive, Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-IFR50-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Côte d'Azur (UCA), CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Pontchaillou [Rennes], Service de pneumologie [Rennes] = Pneumology [Rennes], Service de pneumologie, oncologie thoracique et soins intensifs respiratoires [Rouen], Hôpital Charles Nicolle [Rouen]-CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU), Hôpital Villefranche sur Saône, Service de Pneumologie, Centre Hospitalier du Pays d'Aix, Stress Oxydant et Pathologies Métaboliques (SOPAM), Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Limoges, Université de Brest (UBO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Brestois Santé Agro Matière (IBSAM), Université Nice Sophia Antipolis (1965 - 2019) (UNS), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)

المصدر: The Journal of Thoracic and Cardiovascular Surgery
The Journal of Thoracic and Cardiovascular Surgery, 2019, ⟨10.1016/j.jtcvs.2019.09.193⟩

مصطلحات موضوعية: Male, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Vital capacity, Lung Neoplasms, Time Factors, [SDV]Life Sciences [q-bio], Vital Capacity, [SDV.BC]Life Sciences [q-bio]/Cellular Biology, 030204 cardiovascular system & hematology, law.invention, 03 medical and health sciences, Postoperative Complications, 0302 clinical medicine, Randomized controlled trial, Risk Factors, law, Carcinoma, Non-Small-Cell Lung, Forced Expiratory Volume, Preoperative Care, Clinical endpoint, medicine, Humans, Pneumonectomy, Lung cancer, Lung, ComputingMilieux_MISCELLANEOUS, Aged, COPD, Lung cancer surgery, Noninvasive Ventilation, Intention-to-treat analysis, business.industry, [SDV.BA]Life Sciences [q-bio]/Animal biology, Postoperative complication, Middle Aged, [SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences, medicine.disease, 3. Good health, Surgery, Treatment Outcome, 030228 respiratory system, Female, France, Cardiology and Cardiovascular Medicine, business, [SDV.AEN]Life Sciences [q-bio]/Food and Nutrition

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46eefa09bd5221de4b7d7880fe2af415
https://hal.archives-ouvertes.fr/hal-02543188

المؤلفون: Fabrice Barlesi, Nathalie Cozic, L. Moreau, Henri Berard, Denis Moro-Sibilot, Ludovic Lacroix, Julien Mazieres, Radj Gervais, Cécile Jovelet, Jean-Charles Soria, Elodie Amour, Benjamin Besse, Pierre Jean Souquet, Gérard Zalcman, Virginie Westeel, Olivier Molinier, Jaafar Bennouna, Franck Morin, D. Vasseur

المصدر: Journal of Clinical Oncology. 39:8526-8526

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, medicine.medical_treatment, Minimal residual disease, Circulating biomarkers, Internal medicine, medicine, Micrometastatic disease, In patient, business, Adjuvant

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::32ebb56c5acebd3f0fca5e5ac962e325
https://doi.org/10.1200/jco.2021.39.15_suppl.8526

المؤلفون: Olivier Molinier, Jaafar Bennouna, L. Moreau, Jean-Charles Soria, Laureen Ribassin-Majed, Stephane Jacquot, Denis Moro-Sibilot, Benjamin Lacas, J.P. Pignon, Franck Morin, Bernard Milleron, Didier Debieuvre, Radj Gervais, Fabrice Barlesi, P.J. Souquet, Hervé Lena, L. Petit, Benjamin Besse, Gérard Zalcman, Julien Mazieres, Henri Berard

المصدر: Annals of Oncology. 28:1078-1083

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Indazoles, Population, Kaplan-Meier Estimate, Placebo, Gastroenterology, Disease-Free Survival, Pazopanib, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Carcinoma, Non-Small-Cell Lung, Internal medicine, medicine, Clinical endpoint, Humans, 030212 general & internal medicine, Stage (cooking), Lung cancer, education, Protein Kinase Inhibitors, Aged, Neoplasm Staging, Sulfonamides, education.field_of_study, Dose-Response Relationship, Drug, business.industry, Hematology, Middle Aged, medicine.disease, Interim analysis, Confidence interval, Pyrimidines, Oncology, 030220 oncology & carcinogenesis, Female, Neoplasm Recurrence, Local, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d6c83ff36fe061a19b27fbdbcdeb806
https://doi.org/10.1093/annonc/mdx070

المؤلفون: Nicolas Paleiron, Jacques Margery, Christos Chouaid, Olivier Tiffet, Henri Berard, Mallorie Kerjouan, Isabelle Pichon, Frédéric Gagnadoux, Christine Donzel-Raynaud, Thomas Egenod, Christophe Lancelin, Angelina Dion, Francis Couturaud, Jacques Le Treut, Lionel Falchero, Cécile Tromeur, Nicolas Venissac, Antoine Cuvelier, F. Grassin

المصدر: Thoracic Surgery.

مصطلحات موضوعية: medicine.medical_specialty, Randomized controlled trial, business.industry, law, medicine, Postoperative complication, Lung surgery, business, Pre operative, Surgery, law.invention

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::770e97d56583159b804ffa0f24aefc41
https://doi.org/10.1183/13993003.congress-2018.oa3841